Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation

PHASE4CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Atrial Fibrillation
Interventions
DRUG

Dronedarone

"Pharmaceutical form: tablet~Route of administration: oral (together with meal)~Dose regimen: 400 mg twice daily"

Trial Locations (40)

2300

Investigational Site Number 208-003, København S

2400

Investigational Site Number 208-002, Copenhagen

8000

Investigational Site Number 208-001, Aarhus

11340

Investigational Site Number 484002, México

12808

Investigational Site Number 203001, Prague

19000

Investigational Site Number 203004, Prague

20020

Investigational Site Number 484003, Aguascalientes

26101

Investigational Site Number 203008, Příbram

27000

Investigational Site Number 484004, Torreón

27280

Investigational Site Number 203003, Kladno

28046

Investigational Site Number 724002, Madrid

28342

Investigational Site Number 724006, Valdemoro

29010

Investigational Site Number 724003, Málaga

31059

Investigational Site Number 250-006, Toulouse

34295

Investigational Site Number 250-001, Montpellier

37171

Investigational Site Number 250-003, Chambray-lès-Tours

38043

Investigational Site Number 250-002, Grenoble

38301

Investigational Site Number 203007, Prachatice

45200

Investigational Site Number 484006, Zapopan

48903

Investigational Site Number 724004, Barakaldo

53105

Investigational Site Number 276-001, Bonn

58095

Investigational Site Number 276-005, Hagen

72244

Investigational Site Number 484001, San Luis Potosí City

78200

Investigational Site Number 484005, San Luis Potosí City

78501

Investigational Site Number 203006, Sternberk

80054

Investigational Site Number 250-004, Amiens

90402

Investigational Site Number 276-003, Nuremberg

92104

Investigational Site Number 250-005, Boulogne-Billancourt

Unknown

Investigational Site Number 170001, Bogotá

Investigational Site Number 170002, Bucaramanga

Investigational Site Number 170003, Cartagena

Investigational Site Number 170006, Cartagena

Investigational Site Number 170007, Floridablanca

Investigational Site Number 170005, Medellín

Investigational Site Number 203005, Brno

Investigational Site Number 203002, Olomouc

09111

Investigational Site Number 276-002, Chemnitz

04779

Investigational Site Number 276-004, Wermsdorf

08036

Investigational Site Number 724001, Barcelona

08907

Investigational Site Number 724005, L'Hospitalet de Llobregat

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY